CR
Cyriac Roeding
PersonHeard in 1 episode across 1 show since Oct 2026
Cyriac Roeding is the co-founder and chief executive officer of Earli, a biotechnology company focused on reprogramming cancer cells for detection and treatment.
Episodes
1
across 1 show
First heard
Oct 2026
Guest appearances
1
Episodes per month
Public PodLume episodes featuring it, over the last year.
1
Show the data
| Month | Episodes |
|---|---|
| Nov 2025 | 0 |
| Dec 2025 | 0 |
| Jan 2026 | 0 |
| Feb 2026 | 0 |
| Mar 2026 | 0 |
| Apr 2026 | 0 |
| May 2026 | 0 |
| Jun 2026 | 0 |
| Jul 2026 | 0 |
| Aug 2026 | 0 |
| Sep 2026 | 0 |
| Oct 2026 | 1 |
What Cyriac Roeding has said on podcasts
27 statements
Software may eventually treat many diseases.
“Perhaps one day we will be able to treat many diseases by using software.”
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac RoedingListen at 13:27
Cancer drugs cause major toxicities in the body.
“The main problem we're trying to attack is what we believe is the number one problem of all cancer drugs, which is when they go into the body, they cause major toxicities.”
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac RoedingListen at 20:43
Tumor-localized drug production would limit systemic toxicity.
“If you could do that, then you would suddenly have very limited systemic toxicity.”
Open the episode · Reprogramming Cancer And Competing With China With Earli's Cyriac RoedingListen at 22:27
Statements are attributed to the speaker as said on the episode and reflect their view at the time, not PodLume's. They are not advice.
Episodes
1 episode featuring Cyriac Roeding, newest first